The UK Technology Strategy Board has announced a multi-million dollar investment in healthcare projects. The funding includes £25.9 million from the latest round of the Biomedical Catalyst, £38 million for a National Biologics Industry Innovation Centre in Darlington and £29.3 million investment through three competitions for healthcare innovation funding.
The Biomedical Catalyst launched in 2011 and funds small and medium-sized businesses and researchers looking to work individually or together to develop solutions to healthcare challenges. Three categories of grant are available: feasibility award, early-stage award and late-stage award. Round 4 is now open for applications for early and late-stage awards.
In addition to the Biomedical Catalyst funding, the TSB has awarded £25.9 million in three healthcare funding competitions related to patient-specific approaches to healthcare, diagnostic tests for tuberculosis and regenerative medicine and cell therapy.
The National Biologics Industry Innovation Centre in Darlington, which received a £38 million investment, will be used to fund manufacturing of biological medicines such as antibodies and vaccines.
Details of the programs that received funding can be found on TSB’s website.Camilla Andersson